Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1997 Aug;179(15):4706–4712. doi: 10.1128/jb.179.15.4706-4712.1997

A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly.

C von Eiff 1, C Heilmann 1, R A Proctor 1, C Woltz 1, G Peters 1, F Götz 1
PMCID: PMC179315  PMID: 9244256

Abstract

Although small-colony variants (SCVs) of Staphylococcus aureus have been recognized for many years, this phenotype has only recently been related to persistent and recurrent infections. Clinical S. aureus SCVs are frequently auxotrophic for menadione or hemin, two compounds involved in the biosynthesis of the electron transport chain elements menaquinone and cytochromes, respectively. While this observation as well as other biochemical characteristics of SCVs suggests a link between electron-transport-defective strains and persistent infections, the strains examined thus far have been genetically undefined SCVs. Therefore, we generated a stable mutant in electron transport by interrupting one of the hemin biosynthetic genes, hemB, in S. aureus by inserting an ermB cassette into hemB. We isolated a hemB mutant, due to homologous recombination, by growth at a nonpermissive temperature and selection for erythromycin resistance. This mutant showed typical characteristics of clinical SCVs, such as slow growth, decreased pigment formation, low coagulase activity, reduced hemolytic activity, and resistance to aminoglycosides. Additionally, the mutant was able to persist within cultured endothelial cells due to decreased alpha-toxin production. Northern and Western blot analyses showed that expression of alpha-toxin and that of protein A were markedly reduced, at both the mRNA and the protein level. The SCV phenotype of the hemB mutant was reversed by growth with hemin or by complementation with intact hemB. Hence, a defect in the electron transport system allows S. aureus SCVs to resist aminoglycosides and persist intracellularly.

Full Text

The Full Text of this article is available as a PDF (619.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acar J. F., Goldstein F. W., Lagrange P. Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J Clin Microbiol. 1978 Aug;8(2):142–147. doi: 10.1128/jcm.8.2.142-147.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baddour L. M., Christensen G. D. Prosthetic valve endocarditis due to small-colony staphylococcal variants. Rev Infect Dis. 1987 Nov-Dec;9(6):1168–1174. doi: 10.1093/clinids/9.6.1168. [DOI] [PubMed] [Google Scholar]
  3. Baddour L. M., Simpson W. A., Weems J. J., Jr, Hill M. M., Christensen G. D. Phenotypic selection of small-colony variant forms of Staphylococcus epidermidis in the rat model of endocarditis. J Infect Dis. 1988 Apr;157(4):757–763. doi: 10.1093/infdis/157.4.757. [DOI] [PubMed] [Google Scholar]
  4. Balwit J. M., van Langevelde P., Vann J. M., Proctor R. A. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis. 1994 Oct;170(4):1033–1037. doi: 10.1093/infdis/170.4.1033. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  6. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-1993. A 69-year-old woman with a sclerotic lesion of the femur and pulmonary nodules. N Engl J Med. 1993 Feb 11;328(6):422–428. doi: 10.1056/NEJM199302113280609. [DOI] [PubMed] [Google Scholar]
  7. Cheung A. L., Eberhardt K. J., Fischetti V. A. A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal Biochem. 1994 Nov 1;222(2):511–514. doi: 10.1006/abio.1994.1528. [DOI] [PubMed] [Google Scholar]
  8. Granick S., Beale S. I. Hemes, chlorophylls, and related compounds: biosynthesis and metabolic regulation. Adv Enzymol Relat Areas Mol Biol. 1978;46:33–203. doi: 10.1002/9780470122914.ch2. [DOI] [PubMed] [Google Scholar]
  9. Götz F. Staphylococcus carnosus: a new host organism for gene cloning and protein production. Soc Appl Bacteriol Symp Ser. 1990;19:49S–53S. doi: 10.1111/j.1365-2672.1990.tb01797.x. [DOI] [PubMed] [Google Scholar]
  10. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983 Jun 5;166(4):557–580. doi: 10.1016/s0022-2836(83)80284-8. [DOI] [PubMed] [Google Scholar]
  11. Heinrichs J. H., Bayer M. G., Cheung A. L. Characterization of the sar locus and its interaction with agr in Staphylococcus aureus. J Bacteriol. 1996 Jan;178(2):418–423. doi: 10.1128/jb.178.2.418-423.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Iordanescu S., Surdeanu M. Two restriction and modification systems in Staphylococcus aureus NCTC8325. J Gen Microbiol. 1976 Oct;96(2):277–281. doi: 10.1099/00221287-96-2-277. [DOI] [PubMed] [Google Scholar]
  13. Jones R. N. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med. 1996 Jun 24;100(6A):3S–12S. doi: 10.1016/s0002-9343(96)00102-7. [DOI] [PubMed] [Google Scholar]
  14. Kafala B., Sasarman A. Cloning and sequence analysis of the hemB gene of Staphylococcus aureus. Can J Microbiol. 1994 Aug;40(8):651–657. doi: 10.1139/m94-103. [DOI] [PubMed] [Google Scholar]
  15. Khan S. A., Novick R. P. Terminal nucleotide sequences of Tn551, a transposon specifying erythromycin resistance in Staphylococcus aureus: homology with Tn3. Plasmid. 1980 Sep;4(2):148–154. doi: 10.1016/0147-619x(80)90004-9. [DOI] [PubMed] [Google Scholar]
  16. Koo S. P., Bayer A. S., Sahl H. G., Proctor R. A., Yeaman M. R. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun. 1996 Mar;64(3):1070–1074. doi: 10.1128/iai.64.3.1070-1074.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Korovessis P., Fortis A. P., Spastris P., Droutsas P. Acute osteomyelitis of the patella 50 years after a knee fusion for septic arthritis. A case report. Clin Orthop Relat Res. 1991 Nov;(272):205–207. [PubMed] [Google Scholar]
  18. Lee J. C. Electrotransformation of Staphylococci. Methods Mol Biol. 1995;47:209–216. doi: 10.1385/0-89603-310-4:209. [DOI] [PubMed] [Google Scholar]
  19. Lewis L. A., Li K., Bharosay M., Cannella M., Jorgenson V., Thomas R., Pena D., Velez M., Pereira B., Sassine A. Characterization of gentamicin-resistant respiratory-deficient (res-) variant strains of Staphylococcus aureus. Microbiol Immunol. 1990;34(7):587–605. doi: 10.1111/j.1348-0421.1990.tb01035.x. [DOI] [PubMed] [Google Scholar]
  20. Li J. M., Umanoff H., Proenca R., Russell C. S., Cosloy S. D. Cloning of the Escherichia coli K-12 hemB gene. J Bacteriol. 1988 Feb;170(2):1021–1025. doi: 10.1128/jb.170.2.1021-1025.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McDevitt D., Francois P., Vaudaux P., Foster T. J. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol. 1995 Jun;16(5):895–907. doi: 10.1111/j.1365-2958.1995.tb02316.x. [DOI] [PubMed] [Google Scholar]
  22. McDevitt D., Francois P., Vaudaux P., Foster T. J. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol. 1994 Jan;11(2):237–248. doi: 10.1111/j.1365-2958.1994.tb00304.x. [DOI] [PubMed] [Google Scholar]
  23. Mulligan M. E., Murray-Leisure K. A., Ribner B. S., Standiford H. C., John J. F., Korvick J. A., Kauffman C. A., Yu V. L. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 1993 Mar;94(3):313–328. doi: 10.1016/0002-9343(93)90063-u. [DOI] [PubMed] [Google Scholar]
  24. Musher D. M., Baughn R. E., Templeton G. B., Minuth J. N. Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J Infect Dis. 1977 Sep;136(3):360–369. doi: 10.1093/infdis/136.3.360. [DOI] [PubMed] [Google Scholar]
  25. Musher D. M., McKenzie S. O. Infections due to Staphylococcus aureus. Medicine (Baltimore) 1977 Sep;56(5):383–409. doi: 10.1097/00005792-197709000-00002. [DOI] [PubMed] [Google Scholar]
  26. Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology. 1967 Sep;33(1):155–166. doi: 10.1016/0042-6822(67)90105-5. [DOI] [PubMed] [Google Scholar]
  27. Pelletier L. L., Jr, Richardson M., Feist M. Virulent gentamicin-induced small colony variants of Staphylococcus aureus. J Lab Clin Med. 1979 Aug;94(2):324–334. [PubMed] [Google Scholar]
  28. Proctor R. A., Balwit J. M., Vesga O. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis. 1994 Dec;3(6):302–312. [PubMed] [Google Scholar]
  29. Proctor R. A., van Langevelde P., Kristjansson M., Maslow J. N., Arbeit R. D. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis. 1995 Jan;20(1):95–102. doi: 10.1093/clinids/20.1.95. [DOI] [PubMed] [Google Scholar]
  30. Quie P. G. Microcolonies (G-variants) of Staphylococcus aureus. Yale J Biol Med. 1969 Apr;41(5):394–403. [PMC free article] [PubMed] [Google Scholar]
  31. Sompolinsky D., Schwartz D., Samra Z., Steinmetz J., Siegman-Igra Y. Septicemia with two distinct strains of Staphylococcus aureus and dwarf variants of both. Isr J Med Sci. 1985 May;21(5):434–440. [PubMed] [Google Scholar]
  32. Spagna V. A., Fass R. J., Prior R. B., Slama T. G. Report of a case of bacterial sepsis caused by a naturally occurring variant form of Staphylococcus aureus. J Infect Dis. 1978 Aug;138(2):277–278. doi: 10.1093/infdis/138.2.277. [DOI] [PubMed] [Google Scholar]
  33. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med. 1994 Apr 28;330(17):1247–1251. doi: 10.1056/NEJM199404283301725. [DOI] [PubMed] [Google Scholar]
  34. Vandenesch F., Kornblum J., Novick R. P. A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J Bacteriol. 1991 Oct;173(20):6313–6320. doi: 10.1128/jb.173.20.6313-6320.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Vann J. M., Proctor R. A. Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysin. Microb Pathog. 1988 Jun;4(6):443–453. doi: 10.1016/0882-4010(88)90029-0. [DOI] [PubMed] [Google Scholar]
  36. Vesga O., Groeschel M. C., Otten M. F., Brar D. W., Vann J. M., Proctor R. A. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis. 1996 Mar;173(3):739–742. doi: 10.1093/infdis/173.3.739. [DOI] [PubMed] [Google Scholar]
  37. WISE R. I., SPINK W. W. The influence of antibiotics on the origin of small colonies (G variants) of Micrococcus pyogenes var. aureus. J Clin Invest. 1954 Dec;33(12):1611–1622. doi: 10.1172/JCI103041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wieland K. P., Wieland B., Götz F. A promoter-screening plasmid and xylose-inducible, glucose-repressible expression vectors for Staphylococcus carnosus. Gene. 1995 May 26;158(1):91–96. doi: 10.1016/0378-1119(95)00137-u. [DOI] [PubMed] [Google Scholar]
  39. Wilson S. G., Sanders C. C. Selection and characterization of strains of Staphylococcus aureus displaying unusual resistance to aminoglycosides. Antimicrob Agents Chemother. 1976 Sep;10(3):519–525. doi: 10.1128/aac.10.3.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985;33(1):103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  41. van de Rijn I., Kessler R. E. Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun. 1980 Feb;27(2):444–448. doi: 10.1128/iai.27.2.444-448.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES